Healius (ASX:HLS) Announces Pathology Strategy and $300M Dividend at Investor Day 2025
Healius (ASX:HLS) reveals a new pathology strategy and a $300 million special dividend during Investor Day 2025.
Category: ASX-HLS
Healius
Latest News
4DMedical Limited (ASX:4DX) Secures $22.6M Through Option Exercises
OpenLearning Limited (ASX:OLL) Signs SaaS Agreement with University of the Philippines Manila
Fiducian Group Limited (ASX:FID) Responds to ASIC Civil Proceedings
Eureka Group Holdings Limited (ASX:EGH) Acquires Hillside Garden Village in Perth
The Calmer Co. International Limited (ASX:CCO) Reports $8M Revenue in FY25
Race Oncology (ASX:RAC) Discovers RCDS1 Mechanism of Action
Webjet Group (ASX:WJL) Completes Locomote Acquisition
Yandal Resources (ASX:YRL) Announces $13.5M Placement to Expand Exploration
Eagers Automotive (ASX:APE) Acquires CanadaOne Auto Group
Ryzon Materials Ltd (ASX:RYZ) Expands Engineering Agreement and Secures Capital Raising with Xinhai
The Hub of Australian Finance News